, given that
the vessel wall or atherosclerosis can continue to impede
device delivery even after endoconduit placement, especially when there is bulky calciÔ¨Åc disease.193
In a retrospective series comparing open iliac conduit
with endoconduit including 39 patients (23 open conduits, 16 endoconduits), the iliofemoral complication
rate was 20% for the entire cohort, but it was